Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Sequent Scientific Limited ( (IN:SEQUENT) ).
SeQuent Scientific Limited and Viyash Lifesciences have received approval from the National Company Law Tribunal for their merger, marking a significant transformation in the global animal health market. The merger is expected to create a leading animal health powerhouse, leveraging synergies to enhance financial performance and capitalize on growth opportunities in the fast-growing companion animal health segment and the genericization of animal health. This strategic move aims to accelerate organic growth, enhance financial resilience, and position the combined entity as a world-class provider of innovative animal health solutions.
More about Sequent Scientific Limited
SeQuent Scientific Limited is a prominent player in the global Animal Health industry, focusing on providing solutions for companion and farm animals. The company is involved in the development of APIs and formulations, with a strong emphasis on R&D and custom development capabilities.
Average Trading Volume: 90,367
Technical Sentiment Signal: Buy
Current Market Cap: 57.53B INR
For an in-depth examination of SEQUENT stock, go to TipRanks’ Overview page.